"Whether you need care for a life-threatening or life-limiting neurological condition, MultiCare is committed to providing the highest level of care through leading-edge technology, the most qualified professionals, comprehensive treatment choices and respect for the individual."

During the past decade, MultiCare Neuroscience Center of Washington conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MultiCare Neuroscience Center of Washington" are "Mild or Moderate Surgical Bleeding" (1 trials), "Multiple Sclerosis" (1 trials) and "Neuralgia, Postherpetic" (1 trials). Many other conditions were trialed in "MultiCare Neuroscience Center of Washington" in a lesser frequency.

Most popular intervention types in "MultiCare Neuroscience Center of Washington" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AGN-214868" (1 trials), "AGN-214868 Placebo (Vehicle)" (1 trials), "Fibrocaps" (1 trials), "Gelatin sponge" (1 trials) and "Ocrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "MultiCare Neuroscience Center of Washington" are 3 trials for "All" genders.

Currently, there are NaN active trials in "MultiCare Neuroscience Center of Washington". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MultiCare Neuroscience Center of Washington, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MultiCare Neuroscience Center of Washington, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".